FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/02/080414 [Registered on: 12/02/2025] Trial Registered Prospectively
Last Modified On: 09/02/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Unani
Diagnostic 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Effect Of Oil Amla Khas And Oil Hina With Drugs Like Shoneez And Mom In Androgenic Alopecia A Randomized Single Blind Controlled Trial 
Scientific Title of Study   Efficacy of Roghan Amla Khas versus Roghan Hina with Shoneez and Mom In Androgenic Alopecia (Sala) – A Randomized Single-Blind Comparative Clinical Trial 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Shaikh Zoya Rashid Ahmed  
Designation  PG scholar  
Affiliation  National Institute Of Unani Medicine  
Address  Department Of Amraze Jild Wa Tazeeniyat National Institute Of Unani Medicine Kottigepalya Magadi Main Road Bangalore 560091 Karnataka India

Bangalore
KARNATAKA
560091
India 
Phone  8169947793  
Fax    
Email  zoyashaheryar46@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Prof mohd Aleemuddin Quamri 
Designation  HOD Amraze Jild Wa Tazeeniyat & moalajat (i/c) 
Affiliation  National Institute Of Unani Medicine  
Address  Department Of Amraze Jild Wa Tazeeniyat Ic Moalajat National Institute Of Unani Medicine Kottigepalya Magadi Main Road Bangalore 560091 Karnataka India

Bangalore
KARNATAKA
560091
India 
Phone  9341072974  
Fax    
Email  drmaquamri@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Prof mohd Aleemuddin Quamri 
Designation  HOD Amraze Jild Wa Tazeeniyat & moalajat (i/c) 
Affiliation  National Institute Of Unani Medicine  
Address  Department Of Amraze Jild Wa Tazeeniyat Ic Moalajat National Institute Of Unani Medicine Kottigepalya Magadi Main Road Bangalore 560091 Karnataka India

Bangalore
KARNATAKA
560091
India 
Phone  9341072974  
Fax    
Email  drmaquamri@gmail.com  
 
Source of Monetary or Material Support  
National Institute Of Unani Medicine 
 
Primary Sponsor  
Name  National Institute Of Unani Medicine 
Address  Department Of Amraze Jild Wa Tazeeniyat National Institute Of Unani Medicine Kottigepalya Magadi Main Road Bangalore 560091 Karnataka India 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Shaikh Zoya Rashid Ahmed  National Institute Of Unani Medicine   Department Of Amraze Jild Wa Tazeeniyat OPD/IPD ,National Institute Of Unani Medicine Kottigepalya Magadi Main Road Bangalore 560091 Karnataka India
Bangalore
KARNATAKA 
8169947793

zoyashaheryar46@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Communication of Decision of the Institutional Ethics Committee (IEC) for Biomedical Research   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: L649||Androgenic alopecia, unspecified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  NIL   NIL 
Intervention  Roghan Amla Khas  10 ml of oil for Local application on the scalp with gentle massage daily twice a day. 
Intervention  Roghan Hina with Shoneez and Mom   10 ml of oil for Local application on the scalp with gentle massage daily twice a day. 
 
Inclusion Criteria  
Age From  20.00 Year(s)
Age To  50.00 Year(s)
Gender  Male 
Details  1.Known Cases Of Androgenic Alopecia In Male Subject With Age 20-50 Years
2.Subjects With Grade I to IV AGA According To The Modified Norwood-Hamilton Scale  
 
ExclusionCriteria 
Details  1.Subjects having diseases like scalp psoriasis, tinea capitis, Lichen Planopilaris, Trichotillomania, scarring alopecia, and alopecia areata
2.Subjects with history of CAM (complementary and alternative medicine) therapy or anti-androgenic medications or drugs causing hypertrichosis (phenytoin, acetazolamide, cyclosporine, diazoxide, psoralens, penicillamine, streptomycin and cortisone) or hypotrichosis (anti-coagulants, retinoids, lithium and beta blockers), use of finasteride or other 5-a reductase inhibitors or topical minoxidil within 01 month prior to enrolment
3.Subject with History of hair transplantation.
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Pharmacy-controlled Randomization 
Blinding/Masking   Participant Blinded 
Primary Outcome  
Outcome  TimePoints 
• Change in Trichoscopy Features (Hair shaft thickness heterogeneity, peripilar sign, follicular unit with single hair and yellow dots)  0th Day,15th Day,30th Day, 45th Day,60th Day 
 
Secondary Outcome  
Outcome  TimePoints 
•Decrement in score of Patient Self Assessment Questionnaire
•Investigator Assessment Using Photography
•Decrement In score of Hair Specific Skindex-29
 
0th Day,15th Day,30th Day, 45th Day,60th Day 
 
Target Sample Size   Total Sample Size="34"
Sample Size from India="34" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   01/03/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

Objectives of the study:

To evaluate the comparative efficacy of Roghan Amla Khas versus Roghan Hina with Shoneez and Mom in Androgenic alopecia (Sala).

Study design: A Randomized Single Blind Comparative Clinical Trial

Interventions:

Topical drug in Group 1:Roghan Amla Khas

Topical drug in Group 2:Roghan Hina with  Shoneez and Mom

Main Outcome Measures:

Primary endpoints

       Change in Trichoscopy Features (Hair shaft thickness heterogeneity, peripilar sign,  follicular unit with single hair and yellow dots)

Secondary Endpoint

       Decrement in score of Patient Self Assessment Questionnaire

       Investigator Assessment Using Photography

       Decrement In score of Hair Specific Skindex-29


 
Close